Lexpos News

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Isosorbide mononitrate 10mg, 20mg and 40mg tablets (immediate-release) MSN/2024/114 Tier 2 – medium impact Date of issue: 19th December 2024 Isosorbide mononitrate 10mg and 20mg immediate-release (IR) tablets are in limited supply until late February 2025. Isosorbide mononitrate 40mg IR tablets [...]

The post Medicine Supply Notification: Isosorbide mononitrate 10mg, 20mg and 40mg tablets (immediate-release) appeared first on Community Pharmacy England.

The Health Secretary Wes Streeting MP appeared before the Health and Social Care Select Committee in Parliament yesterday (December 18th) to answer questions related to his brief.   In response to questions – including from All-Party Parliamentary Group on Pharmacy Member Gregory Stafford MP – the Secretary of State said he wanted to: “reassure pharmacies across [...]

The post Health Secretary pledges to take ‘enormous’ pharmacy pressures into account appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV) Drug alert number: EL (24)A/63 Date issued: 19 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Vyvgart 1000 mg solution for injection (Argenx BV) DMRC reference number: DMRC-34131563 Company name:Argenx [...]

The post MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV) appeared first on Community Pharmacy England.

Daily Mail, Daily Express  Many community pharmacies will not survive this winter season without urgent financial support, pharmacy leaders have warned. Latest polling data from Community Pharmacy England (conducted during October and November 2024) highlights alarming findings from pharmacy owners representing over 3,500 pharmacies in England and 55 senior local pharmacy leaders. Without urgent intervention, [...]

The post Pharmacy closures and patient safety risks on horizon appeared first on Community Pharmacy England.

National Patient Safety Alert: Shortage of Pancreatic enzyme replacement therapy (PERT) – Additional actions National Patient Safety Alert Reference Number: NatPSA/2024/013/DHSC Date issued: 18 Dec 2024 Explanation of identified safety issue This alert contains actions which are in addition to those outlined in the National Patient Safety Alert (NatPSA/2024/007/DHSC) issued on 24th May 2024. There [...]

The post National Patient Safety Alert: Shortage of Pancreatic enzyme replacement therapy (PERT) – Additional actions appeared first on Community Pharmacy England.